Status:
RECRUITING
Reinnervated PAP Flap for Oral Cavity and Oropharyngeal Defect Reconstruction
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Oral Cavity Defect
Oropharynx Defect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to investigate sensory recovery and functional outcomes following oral cavity and oropharyngeal defect reconstruction with reinnervated PAP (profunda artery perforator) flaps.
Detailed Description
Tumor resections involving the oral cavity or oropharynx cause significant functional deficits in swallowing and speech and subsequently impair the patients' quality of life. The anterolateral thigh (...
Eligibility Criteria
Inclusion
- \- Patient with defect involving the oral cavity or oropharynx who undergo reconstruction with a free reinnervated profunda artery perforator flap
Exclusion
- \<18 years old
- Defect localizations other than the oral cavity or oropharynx
- Not able to give informed consent
- Inability to follow the procedures of the study, e.g., due to psychological disorders, dementia
- Inability or contraindications to undergo the investigated intervention
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05997186
Start Date
September 1 2023
End Date
May 1 2027
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031